Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inoviq Ltd (AU:IIQ)
ASX:IIQ
Holding AU:IIQ?
Track your performance easily
IIQ Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.43 - AU$0.92
Previous CloseAU$0.46
Volume38.46K
Average Volume (3M)66.73K
Market Cap
AU$52.42M
Enterprise ValueAU$38.02M
Total Cash (Recent Filing)AU$15.39M
Total Debt (Recent Filing)AU$998.69K
Price to Earnings (P/E)―
Beta0.97
Next Earnings
Feb 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares OutstandingN/A
10 Day Avg. Volume37,504
30 Day Avg. Volume66,730
Standard Deviation0.54
R-Squared0.03
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)133.88
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Inoviq Ltd News
PremiumCompany Announcements
INOVIQ Ltd Expands in Cancer Diagnostics Market
PremiumCompany Announcements
Inoviq Ltd Announces Upcoming Annual General Meeting
PremiumCompany Announcements
INOVIQ Ltd Issues New Options, Advances Cancer Diagnostics
PremiumCompany Announcements
Inoviq Ltd Applies for New ASX Options Quotation
PremiumCompany Announcements
INOVIQ Ltd Welcomes New Director Harney
PremiumCompany Announcements
INOVIQ Director’s Holdings Unchanged Post Options Expiry
PremiumCompany Announcements
INOVIQ Advances Cancer Diagnostics and Care
PremiumCompany Announcements
Inoviq Ltd Witnesses Substantial Holder ActivityOptions Prices
Currently, No data available
---
Ownership Overview
IIQ FAQ
What was Inoviq Ltd’s price range in the past 12 months?
Inoviq Ltd lowest share price was AU$0.43 and its highest was AU$0.92 in the past 12 months.
What is Inoviq Ltd’s market cap?
Currently, no data Available
When is Inoviq Ltd’s upcoming earnings report date?
Inoviq Ltd’s upcoming earnings report date is Feb 21, 2025 which is in 91 days.
How were Inoviq Ltd’s earnings last quarter?
Inoviq Ltd released its earnings results on Aug 21, 2024. The company reported -AU$0.037 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.037.
Is Inoviq Ltd overvalued?
According to Wall Street analysts Inoviq Ltd’s price is currently Overvalued.
Does Inoviq Ltd pay dividends?
Inoviq Ltd does not currently pay dividends.
What is Inoviq Ltd’s EPS estimate?
Inoviq Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Inoviq Ltd have?
Inoviq Ltd has 111,526,700 shares outstanding.
What happened to Inoviq Ltd’s price movement after its last earnings report?
Inoviq Ltd reported an EPS of -AU$0.037 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Inoviq Ltd?
Currently, no hedge funds are holding shares in AU:IIQ
---
Inoviq Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IIQ Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth AU$250.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.86%
12-Months-Change
Fundamentals
Return on Equity
-33.10%
Trailing 12-Months
Asset Growth
0.92%
Trailing 12-Months
Company Description
Inoviq Ltd
Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.
---
Technical Analysis
LBT Innovations Limited
―
IDT Australia Limited
―
Cyclopharm Limited
―
Race Oncology Ltd.
―
---